Sionna Therapeutics, Inc. Common Stock Financial Flexibility Index
Sionna Therapeutics, Inc. Common Stock financial flexibility index. Sionna Therapeutics, Inc. Common Stock (SION) has a Financial Flexibility Index of -0.86x as of December 2025. Free cash flow of $-16.42 Million (operating CF $-16.63 Million minus capex $204.00K) represents -1% of total liabilities ($19.12 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Sionna Therapeutics, Inc. Common Stock (2022–2025)
Financial flexibility index of Sionna Therapeutics, Inc. Common Stock from 2022 to 2025. Historical Financial Flexibility Index trend for Sionna Therapeutics, Inc. Common Stock across 4 annual periods. Explore Sionna Therapeutics, Inc. Common Stock cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Sionna Therapeutics, Inc. Common Stock Financial Flexibility Index by Year (2022–2025)
Sionna Therapeutics, Inc. Common Stock financial flexibility index by year from 2022 to 2025. Year-by-year free cash flow to debt coverage for Sionna Therapeutics, Inc. Common Stock. For the full cash flow conversion analysis, see Sionna Therapeutics, Inc. Common Stock cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.45x | $-65.92 Million | $-66.30 Million | $19.12 Million | ▼ -2183.6% |
| 2024 | -0.15x | $-52.76 Million | $-52.79 Million | $349.46 Million | ▲ +40.9% |
| 2023 | -0.26x | $-42.58 Million | $-43.70 Million | $166.83 Million | ▼ -17.4% |
| 2022 | -0.22x | $-34.19 Million | $-36.07 Million | $157.29 Million | — |